Skip to content
Home›Awards›Mapp Biopharmaceutical, INC.
$

Federal Contract Award

Mapp Biopharmaceutical, INC.

Department of Defense · September 16, 2025 · FY2025

HT942525FE048Set-aside not reportedNAICS 325413

Obligated

$60,500

Contract details

Award ID
CONT_AWD_HT942525FE048_9700_HT942525D0009_9700
PIID
HT942525FE048
Period of performance
September 19, 2025 → February 25, 2026
Place of performance
SAN DIEGO, CA, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS
325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Scope

HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS

Parent vehicle (IDV)

Mapp Biopharmaceutical, INC.

UEI M9V9QTHR1H28

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Mapp Biopharmaceutical, INC. →
UEI
M9V9QTHR1H28
CAGE
417U0
Parent
Mapp Biopharmaceutical, INC.
Address
SAN DIEGO, CA

Awarding agency

Department of Defense →
Sub-agency
Defense Health Agency
Office
ARMY MED RES ACQ ACTIVITY
Funding agency
Department of Defense
Funding office
ARMY MED RES INST OF DESEASE - PB

See every contract Mapp Biopharmaceutical, INC. has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Mapp Biopharmaceutical, INC. profile →